Yale Genetic Counselor Weighs in on Myriad Case and More: Ellen Matloff

“Yale Genetic Counselor Weighs in on Myriad Case and More: Ellen Matloff.” Published by Ayanna Monteverdi, Mendelspod.com.

The first genetic counselor at Yale’s School of Medicine, Ellen Matloff has had a front row seat to the long saga of gene patents, particularly the BRCA patents of Myriad Genetics. In today’s interview Ellen recalls the days . . . → Read More: Yale Genetic Counselor Weighs in on Myriad Case and More: Ellen Matloff

A Genetic Counselor Explains How Gene Patents Harmed Her Patients

“A Genetic Counselor Explains How Gene Patents Harmed Her Patients.” By Ellen Matloff, MS, Yale Cancer Center, Breast Cancer Action.

Editor’s Note: On July 13, 2013, the Supreme Court ruled in our favor to overturn Myriad Genetics’ patents on the “breast cancer genes,” BRCA1 and BRCA2. We were proud to be the only breast cancer . . . → Read More: A Genetic Counselor Explains How Gene Patents Harmed Her Patients

Our Genes, Their Secrets

“Our Genes, Their Secrets.” By Eleonore Pauwels, The New York Times.

The Supreme Court’s unanimous ruling last Thursday, barring patents on human genes, was a wise and balanced decision that clears away a major barrier to innovation in the areas of biotechnology, drug development and medical diagnostics. But the decision is just a first step . . . → Read More: Our Genes, Their Secrets

“I Discovered the BRCA1 Gene”

“I Discovered the BRCA1 Gene.” By Sara Reardon, Slate.

Mary-Claire King, the geneticist who discovered the BRCA1 gene, says she is delighted by the U.S. Supreme Court ruling that makes it illegal to patent it. Her work inspired the forthcoming film Decoding Annie Parker, in which she is portrayed by Helen Hunt.

Sara Reardon: . . . → Read More: “I Discovered the BRCA1 Gene”

Supreme Court says natural human genes can't be patented

“Supreme Court says natural human genes can’t be patented.” By Pete Williams and Erin McClam, NBC News.

The Supreme Court ruled unanimously Thursday that natural human genes cannot be patented by companies, but it said that synthetically produced genetic material can — a mixed ruling for the biotechnology industry. A naturally occurring piece of DNA . . . → Read More: Supreme Court says natural human genes can’t be patented

Why Jolie's cancer test costs so much

Published on CNN, May 24, 2013.

(CNN) — Angelina Jolie, when writing about her preventive double mastectomy, did not discuss how much her surgeries cost, but she did mention that many women would not be able to afford the $3,000 to $4,000 test that led her to make the decision. What she failed to say . . . → Read More: Why Jolie’s cancer test costs so much

Patients, Patents, and Profits in a Genomic Age

When the Human Genome Project started in 1990 there were fewer than 100 genes associated with human diseases. The first genetic mutation (for Huntington’s disease) was identified in 1986, just a few years before the Project started. After more than a decade of technological innovation and about $3.8 billion, a team of scientists across more . . . → Read More: Patients, Patents, and Profits in a Genomic Age

Human Gene Patentability Case Heads To Supreme Court

“Human Gene Patentability Case Heads To Supreme Court.” By Sharon Begley, Reuters (via Huffington Post).

The U.S. Patent and Trademark Office has granted patents on at least 4,000 human genes to companies, universities and others that have discovered and decoded them. Patents now cover some 40 percent of the human genome, according to a scientific . . . → Read More: Human Gene Patentability Case Heads To Supreme Court

The Ethical Implications of Gene Patenting

“The Ethical Implications of Gene Patenting” Empowered Doctor.

Do genes qualify as a property that a single individual or corporation is allowed exclusive rights to? On April 15, 2013 the Supreme Court will hear a case that could dictate the future of biomedicine. Currently, Myriad Genetics Corporation, a biotechnology company in Utah, has patented two . . . → Read More: The Ethical Implications of Gene Patenting